GTCbio

MONROVIA, CA – David M. Goldstein, Senior Director and Head of Inflammation Chemistry at Hoffmann-La Roche to speak at GTCbio’s 5th Protein Kinases in Drug Discovery conference May 27-28, 2010 in Boston, MA. David M. Goldstein will give a featured presentation on “Using In-Vitro Assays, including Kinase Selectivity Profiles, to Predict Toxicity In-Vivo”. Internal experience with kinase inhibitors...

Katy Spink, Vice President of Operations for Geron, will give the Featured address entitled “GRNCM1: Human Embryonic Stem Cell Derived Cardiomyocytes for the Treatment of Heart Failure” at GTCbio’s 6th Annual Stem Cell Research & Therapeutics Conference on May 27-28, 2010 in Boston, MA. Dr. Spink will discuss Geron’s GRNCM1 program, in which they are developing hESC-derived cardiomyocytes for...

Barbara Wirostko, Senior Medical Director, Team Lead Ophthalmology, Pfizer will present on Endothelin: A Potential Novel Mechanism for Future Drug Development in Ophthalmology at GTCbio’s 2nd Annual Ocular Disease Drug & Discovery Conference on May 27 – 28, 2010 in Boston, MA. Barbara Wirostko will present her topic on Endothelin as a novel target. The benefits of the talk will cover the...

Joost Oppenheim, Laboratory Chief at the Laboratory of Molecular Immunoregulation – NCI Frederick, is to give a keynote presentation on a group of structurally diverse multifunctional host proteins called “alarmins”, at GTCbio’s 8th Cytokines & inflammation Conference on January 28-29, 2010 in San Diego, CA. Dr. Oppenheims presentation concerns recent studie that have...

The 7th Annual Vaccines: “All Things Considered” conference is to be held this year in Washington, D.C. on Nov 9-10, 2009 by GTCbio. This conference promises to be the one-stop destination to gain updates and exposure on all aspects of vaccine research, development, regulations, and policy.